The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.
The purpose of this study is to design and execute a prospective, longitudinal, descriptive
cohort study in a pragmatic clinical practice for adults with symptoms that may be related to
COVID-19 infection who participate in Chinese herbal medicine (CHM) telehealth visits and
take CHM. CHM includes over 400 medicinal substances and CHM formulas are individualized at
each visit according to the patient's presentation. CHM has been used to treat cough,
shortness of breath, and fatigue and mechanisms of action have been investigated for SARS and
H1N1 influenza prevention and treatment by anti-inflammatory effects and antiviral activity.
Yet, there is a gap in our understanding of the clinical application of CHM in a community
sample of individuals experiencing symptoms that may be related to COVID-19. The
investigators have no pragmatic clinic data about the use of CHM for coronaviruses.
Safe and effective treatment of symptoms associated with COVID-19 is a top international
priority and research is needed to better understand if CHM is a safe intervention to treat
symptoms. Further, dissemination of trustworthy CHM treatment approaches for this complex and
emergent condition is needed within the CHM and scientific communities.
Aim 1: Conduct quantitative analyses of the collected data and disseminate findings to CHM
clinicians and to the scientific community.
Case series will be reported bi-weekly to CHM clinicians via the SIEAM website including
exposure, comorbidities, symptom change, concurrent medications, CHM prescriptions, adverse
events and usability. Data will be analyzed at the study conclusion for presentation to the
scientific community.
Aim 2: Conduct qualitative analyses of the collected data and disseminate findings to CHM
clinicians and to the scientific community.
Chart notes reflecting clinicians' clinical reasoning will be content analyzed and posted
bi-weekly on the SIEAM website. This will provide timely information for the CHM clinical
community from highly experienced clinicians. Data will be analyzed at the study conclusion
for presentation to the scientific community.
Dietary Supplement: Chinese Herbal Medicine
Chinese Herbal Medicine (CHM) has been used in the prevention and treatment of epidemic diseases dating back to the Han, Ming and Qing Dynasties and extending al the way through modern times. CHM formulas may contain plant elements of root, seed, back, stem or leaf in addition to minerals and other natural substances. All herbs dispensed in this trial will be from Spring Wind Herb Company.
Inclusion Criteria:
- Eighteen year of age.
- Experienced one or more of the following symptoms in the last 28 days: cough, fever,
shortness of breath, diarrhea, nausea, or abdominal pain OR am at high risk of
exposure.
- Have a Primary Care Provider.
Exclusion Criteria:
- Breastfeeding, pregnant, or expect that I might be pregnant.
- Ineligible to receive a telehealth consult for any reason.
- Unable to communicate in English verbally, and in writing.
- Have an open legal case about my health.
- Taking anticoagulants, immunosuppressants, antiseizure medications, antipsychotic
medications or am in active cancer treatment
- Taking medications with some risk of interaction with the herbal medicine. This will
be determined at the time of the herbal consult by the clinic team.
- Discretion of the practitioner or screener.
Seattle Intstitute of East Asian Medicine
Seattle, Washington, United States
Investigator: Katherine Taromina, DACM
Contact: 206-517-4541
ktaromina@sieam.edu
Lisa A Taylor-Swanson, PhD
801-585-5486
lisa.taylor-swanson@nurs.utah.edu
Lisa Conboy, DSc
617-718-1917
lisaconboy@gmail.com